CYP21A2 and congenital adrenal hyperplasia: Of the 30 patients harboring CYP21A2 deletions, 40% (12/30) exhibited co-occurring TNXB exon 35 deletions, confirming a diagnosis of CAH-X CH-1 (Table 5; Supplementary Figure S5).